American College of Toxicology

Nonprofit profile at a glance

EIN
363007817
IRS 990 coverage
2011–2025
Forms available
Form 990 2025, Form 990-T 2025
Location
Reston, VA, USA
Phone
7035470875
Rating
70
Verdict
SUPPORTED
Rating confidence
Moderate

Reported finances

Revenue
$3,259,122
Expenses
$2,574,057
Assets
$8,385,806
Liabilities
$349,270

Source: IRS Form 990. Selected filing: tax year 2025. Amounts in USD.

Leadership & pay

21 people listed

Executive titles in this filing

  • PATRICIA RYAN (PRESIDENT-ELECT (THRU NOV)/PRESIDENT (FROM DEC))
  • JEFFREY TEPPER (PRESIDENT (THRU NOV)/PAST PRESIDENT (FROM DEC))
  • PEYTON MYERS (VP (THRU NOV)/PRESIDENT-ELECT (FROM DEC))
  • THOMAS STEINBACH (VICE PRESIDENT (FROM DEC))
  • WILLIAM BROCK (PAST PRESIDENT (THRU NOV))
  • NANCY ROLLMAN (EXECUTIVE DIRECTOR (THRU OCT))

People named in this filing

  • PATRICIA RYAN (PRESIDENT-ELECT (THRU NOV)/PRESIDENT (FROM DEC))
  • JEFFREY TEPPER (PRESIDENT (THRU NOV)/PAST PRESIDENT (FROM DEC))
  • PEYTON MYERS (VP (THRU NOV)/PRESIDENT-ELECT (FROM DEC))

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

The mission of the american college of toxicology is to educate, lead, and serve professionals in toxicology and related disciplines by promoting the exchange of information and perspectives on applied toxicology and safety assessment.

What it reported doing in 2025

Education and information act held four courses during 2025 and 2024.biologics nonclinical drug development - this course provides as comprehensive overview of regulatory and toxicologic considerations in the development of biologics. The principles and methodologies used in nonclinical safety assessments are demonstrated for all stages of drug development. In 2025, the course was attended by 102 participants and speakers. Toxicology for pharmaceutical and regulatory scientists this course was attended by 66 participants in 2025 and 62 participants in 2024. This course provided a basic training in toxicology. Using pharmaceutical developments as examples, participants obtained an overall understanding of the principles of toxicology and nonclinical safety evaluation.pathology for nonpathologists this course is held every other year and lectures are given by highly respected pathologists having current and relevant experience in toxicology pathology. In 2025, the course was not held. In 2024, the course was attended by 33 participants. This course's lectures covered anatomy and physiology, spontaneous and chemically induced pathological changes, and clinical pathology.advanced comprehensive toxicology this course was attended by 60 in 2025 and was attended by 67 participants in 2024. In this intensive course, attendees were provided detailed descriptions of principles of toxicology, effects of xenobiotics on organ systems, mechanisms of toxicity, risk assessment, and regulatory toxicology.practical reproductive and developmental toxicology - this course was not held in 2025 or 2024. This course provided a basic understanding in reproductive and developmental biology and principles of various testing approaches for reproductive and developmental toxicology, with a strong emphasis on the practical application of these principles and interpretation of nonclinical safety data as well as risk assessment.act continued promoting its recorded elearning series, "basic topics in toxicology elearning and "specialty topics elearning, and "specialty oncology biotherapeutics, and "regulatory and nonclinical considerations for the development of cns/neurology therapeutics." these elearning series began in prior years and had a fee to participate. Act also launched a new elearning series in 2025, "back to basics: specialty toxicology studies." act continued to host free quarterly webinars and podcasts in 2025 on current topics in toxicology, including primarily drug and chemical safety assessments. Presenters were experts in their field, with backgrounds in government, industry, or academia.

Operating model

Revenue model
Earned-program. 78% of the money available for current operations came from fees and other program revenue.
Distribution model
Direct operator. The filing allocates 96% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - The filed numbers largely add up and most voting board members are independent. A relatively small share of available resources goes toward mission work and fundraising costs are high for each dollar raised.

Rating breakdown

  • Financial Efficiency: 49
  • Transparency & Controls: 77
  • Accountability: 94
  • Sustainability: 74
  • Growth: 100

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 50.4%; rating input score 50
  • Program expense ratio: 62.2%; rating input score 62
  • Fundraising efficiency: $1.41 raised per $1 spent on fundraising; rating input score 3; 3rd percentile among comparable filings

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: 1 of 8 controls in place; rating input score 12
    • Claims monitoring procedures: Pass
    • Requires narrative reports: Limited
    • Conducts field audits: Limited
    • May suspend future funding: Limited
    • Requires financial reports: Limited
    • Conducts site visits: Limited
    • Requires grant agreements: Limited
    • May require repayment: Limited
  • Grant itemization coverage: 100%; rating input score 100; 75th percentile among comparable filings
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
  • Governance controls: 6 of 7 controls in place; rating input score 86
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Fail
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Pass
    • Independent financial-statement audit: Pass

Sustainability

  • Operating margin: 21%; rating input score 74; 74th percentile among comparable filings
  • Total-asset coverage ratio: 3.26; rating input score 72; 72nd percentile among comparable filings
  • Liabilities to assets ratio: 0.04; rating input score 63; 63rd percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 90; 90th percentile among comparable filings

Growth

  • Program expense growth: 6% per year; rating input score 100; 42nd percentile among comparable filings
  • Revenue growth: 6.8% per year; rating input score 100; 50th percentile among comparable filings
  • Asset growth: 7.8% per year; rating input score 100; 48th percentile among comparable filings

Details

  • Where the money goes: 50.4% of revenue deployed · 62.2% of spending went to programs
  • Governance: 15 of 15 board members independent · 6 of 7 filing controls reported
  • Programs: 3 filed program accomplishments · $1.6M in reported program spending
  • Leadership: top reported pay $0 · 21 people listed
  • Highest-paid contractors: 1 contractor listed · $1.4M reported
  • Consistency: 32 of 32 current checks pass
  • Schedules: 6 filed schedules · includes major donors, foreign activity, and grants
  • Filing history: 14 filing years from 2011 to 2025
  • Contacts: How to reach this organization
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Review — Financial Efficiency: Mission deployment rate scored 50/100.
  • High — Financial Efficiency: Fundraising efficiency scored 3/100.
  • Review — Accountability: Governance controls: Form 990 shared with the board not reported.